AlphAIAlphAI — Financial news for AI agents
benzinga.com$INLF

Why INLIF Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket - INLIF (NASDAQ:IN

INLIF Ltd (NASDAQ:INLF) shares surged 78% to $5.25 in pre-market trading after reporting a 26.01% net revenue increase to $12.94 million for the first half of fiscal 2026. Gross profit rose 158.77% to $4.65 million, and the company posted net income of $1.01 million, reversing a prior-year loss. Other stocks moving in pre-market trading include CTNT, ONCO, IFBD, FTHM, and more.

Original reporting
benzinga.com
Published Sep 25, 2026, 8:40 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 25, 2026, 8:53 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$INLF
Bullish
high confidence
Mentioned
$INLF
Relevance
6/10
AlphAI data visualization · based on benzinga.com
Decision brief

The 30-second read

$INLFBullishHigh
01

Why it matters

The earnings beat drove a 78% pre‑market jump, suggesting strong short‑term buying pressure.

02

Market read

The earnings surprise creates a short‑term trading opportunity for INLF, with limited spillover to the broader market.

03

What to watch

Liquidity constraints of a micro‑cap could amplify volatility; upcoming guidance will be critical.

Relevance 6/10Novelty 7/10Timing: pre‑market today

Background

INLIF Ltd is a micro‑cap SaaS provider that released its unaudited first‑half fiscal 2026 results, showing a significant revenue increase and a swing to net profit.

Company-level read

Ticker impact

$INLFBullishHigh confidence
Context

INLIF reported unaudited H1 2026 results with 26% revenue growth and a 78% pre‑market price jump.

Expected impact

Further upside in intraday trading as investors digest the earnings surprise.

Evidence & confidence

Revenue and profit exceeded prior year, and the stock already rallied 78% pre‑market, indicating high trader interest.

Market effects

Sector

Positive signal for small‑cap SaaS and biotech peers reporting H1 results.

Regional

Limited to U.S. pre‑market activity; no broader regional effect.

Global

Minimal global impact beyond niche investor base.

Counterpoint

What could challenge this read

The rapid price surge may be overbought; a pullback could occur if guidance is modest.

Key entities

  • company
    INLIF Ltd

    Issuer of the earnings release.

Read at source← All news

Related articles

$INLFMed

INLIF Ltd (INLF): Financial results for H1 2026

INLIF Ltd (INLF) furnished an SEC Form 6-K — earnings release. Exhibit 99.3 INLIF LIMITED Reports First Half of Fiscal Year 2026 Financial Results Quanzhou, China, September 24, 2026 /PRNewswire/ -- INLIF LIMITED (Nasdaq: INLF) (together with all its subsidiaries and consolidated entities, the “Company” or “INLIF”), a company engaged in the

SEC EDGAR 6-K
$INLFMedAI 8/10

INLIF LIMITED Accelerates Strategic Layout in New Energy Sector, Securing $4.4 Million First Order for Battery Cell Packing Machines

INLIF Limited (NASDAQ: INLF) said it confirmed commercial delivery of its first battery cell packing machines order, worth nearly RMB 30 million (about US$4.4 million). The contract includes 14 units for a domestic battery manufacturer; the customer also placed a follow-on order for six more units. INLIF estimates up to 50 units by end-2026 (about RMB 100 million+), subject to demand and execution risks.

manilatimes.net
$AVLNMed

Avalyn Reports Third Quarter 2026 Financial Results and Recent

Avalyn Pharma Inc. (AVLN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Avalyn Reports Third Quarter 2026 Financial Results and Recent Business Highlights Initiated Phase 1 study of AP03, a fixed dose combination of nebulized pirfenidone and nintedanib, in healthy volunteers Presented new AP01 data at ERS Congress and published detailed results from

SEC EDGAR 8-K
$MGTXHigh

MeiraGTx Reports Third Quarter 2026 Financial and Operational Results

MeiraGTx Holdings plc (MGTX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 MeiraGTx Reports Third Quarter 2026 Financial and Operational Results ● Submission of Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for botaretigene sparoparvovec (bota-vec) for the treatment of X-linked retinitis pigmentosa (XLRP)

SEC EDGAR 8-K
$VOXRMed

VOX ROYALTY CORP. (VOXR): Financial results for Q3 2026

VOX ROYALTY CORP. (VOXR) furnished an SEC Form 6-K — earnings release. EXHIBIT 99.5 VOX ROYALTY REPORTS Q3 2026 RESULTS AND DECLARES QUARTERLY DIVIDEND DENVER – November 11, 2026 – Vox Royalty Corp. (NASDAQ: VOXR ) (TSX: VOXR ) (“ Vox ” or the “ Company ”), a returns-focused mining royalty and streaming company, is pleased to announce its operating

SEC EDGAR 6-K
$LUCDMed

Lucid Diagnostics Provides Business Update and Reports Third Quarter 2026 Financial Results

Lucid Diagnostics Inc. (LUCD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Lucid Diagnostics Provides Business Update and Reports Third Quarter 2026 Financial Results EsoGuard ® now fully reimbursed by Medicare nationwide, launching a new phase of accelerating commercialization with record monthly test volume to start the fourth quarter Con

SEC EDGAR 8-K